Chandler Robinson, CEO: Monopar Therapeutics MNPR Planned sale · Filed 09/24

Trade details

Type: Planned sale notice
Stock: Monopar Therapeutics MNPR
Person: Chandler RobinsonCEO
Planned sale date: 26/09/24
Filed: 26/09/24

0.4% of shares outstanding to be sold

Monopar Therapeutics trades, last 26 weeks

What else happened in Monopar Therapeutics around then

Filed or reported within 30 days of the trade day · 08/25~10/24

Chandler Robinson's recent trades

Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$910.7K
10,450 sh
$910.7K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$847.8K
9,638 sh
$847.8K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$744.5K
8,368 sh
$744.5K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$53.9K
600 sh
$53.9K
Filed 09/28
Traded 09/24
Chandler RobinsonOther
SellMonopar Therapeutics
Sell
Monopar Therapeutics
MNPR
$35M
550,229 sh
$35M
Filed 25/09/26
Traded 25/09/24